Everyday ScienceIndustry Matters: From Elite Responders to M2 macrophages – OncoResponse’s approach to cancer immunotherapy. Posted on August 31, 2022January 4, 2023 by scientificinquirer0 comments on “Industry Matters: From Elite Responders to M2 macrophages – OncoResponse’s approach to cancer immunotherapy.” Continue reading "Industry Matters: From Elite Responders to M2 macrophages – OncoResponse’s approach to cancer immunotherapy."
Everyday ScienceBest way to kill a tumor? Starve it to death Posted on July 18, 2018July 18, 2018 by scientificinquirer1 comment on “Best way to kill a tumor? Starve it to death” Continue reading "Best way to kill a tumor? Starve it to death"
Everyday ScienceNew neoantigen therapy is a step closer to personalized cancer treatment Posted on July 8, 2017July 7, 2017 by scientificinquirer0 comments on “New neoantigen therapy is a step closer to personalized cancer treatment” Continue reading "New neoantigen therapy is a step closer to personalized cancer treatment"